Ole Andreas Halvorsen
Viking Global Investors
Ole Andreas Halvorsen Edwards Lifesciences Corp stake
total: 670
Viking Global Investors EW trades
- Total transactions:
- 7
- New positions:
- 3
- Sold out:
- 3
- Reduced:
- 1
- Held since:
- 2026 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Ole Andreas Halvorsen doesn't hold any Edwards Lifesciences Corp (EW) shares. To date, the estimated cost basis is nearly $80.08 for "buy" trades and estimated average "sell" price is $80.08. Viking Global Investors first purchased EW in 2019 Q3, initially acquiring 612,444 shares. Ole Andreas Halvorsen later completely sold out the position and invested in Edwards Lifesciences Corp again in 2026 Q1. Since the initial investment in Edwards Lifesciences Corp (EW), Viking Global Investors has made 6 more transactions.
When did Ole Andreas Halvorsen sell Edwards Lifesciences Corp (EW)?
Ole Andreas Halvorsen sold off the entire Edwards Lifesciences Corp (EW) position in 2026 Q2.
When did Ole Andreas Halvorsen buy Edwards Lifesciences Corp (EW)?
Ole Andreas Halvorsen first invested in Edwards Lifesciences Corp (EW) in 2019 Q3 at the reported quarter-end price of $73.30 per share.
What's the cost basis of Viking Global Investors's EW stake?
The estimated cost basis for Edwards Lifesciences Corp (EW) stake is around $80.08 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $80.08
- Weighted AVG sell price:
- $80.08
Ole Andreas Halvorsen's historical trades in Edwards Lifesciences Corp
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
0.00%
|
0
|
$80.08
|
|
-100% (-1,097,578)
|
-0.25%
|
|
2026 Q1
|
0.25%
|
1,097,578
|
$80.08
|
$87,894,046
|
new
|
+0.25%
|
|
2025 Q4
|
0.00%
|
0
|
$77.77
|
|
-100% (-3,069,151)
|
-0.62%
|
|
2025 Q3
|
0.62%
|
3,069,151
|
$77.77
|
$238,687,873
|
new
|
+0.62%
|
|
2020 Q1
|
0.00%
|
$77.76
|
-100% (-475,719)
|
|||
|
2019 Q4
|
0.17%
|
$77.76
|
-22.32% (-136,725)
|
|||
|
2019 Q3
|
0.23%
|
$73.30
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.